RBC Europe’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1
| Closed | -$6 | – | 1187 |
|
|
2021
Q3 | $6 | Hold |
1
| – | – | ﹤0.01% | 1235 |
|
|
2021
Q2 | $17 | Hold |
1
| – | – | ﹤0.01% | 1224 |
|
|
2021
Q1 | $18 | Hold |
1
| – | – | ﹤0.01% | 1174 |
|
|
2020
Q4 | $10 | Hold |
1
| – | – | ﹤0.01% | 1148 |
|
|
2020
Q3 | $6 | Hold |
1
| – | – | ﹤0.01% | 1098 |
|
|
2020
Q2 | $14 | Hold |
1
| – | – | ﹤0.01% | 1061 |
|
|
2020
Q1 | $11 | Hold |
1
| – | – | ﹤0.01% | 1038 |
|
|
2019
Q4 | $74 | Hold |
1
| – | – | ﹤0.01% | 1034 |
|
|
2019
Q3 | $57 | Hold |
1
| – | – | ﹤0.01% | 1038 |
|
|
2019
Q2 | $34 | Hold |
1
| – | – | ﹤0.01% | 1058 |
|
|
2019
Q1 | $31 | Hold |
1
| – | – | ﹤0.01% | 1073 |
|
|
2018
Q4 | $25 | Hold |
1
| – | – | ﹤0.01% | 1085 |
|
|
2018
Q3 | $39 | Hold |
1
| – | – | ﹤0.01% | 1124 |
|
|
2018
Q2 | $17 | Hold |
1
| – | – | ﹤0.01% | 1140 |
|
|
2018
Q1 | $31 | Hold |
1
| – | – | ﹤0.01% | 1118 |
|
|
2017
Q4 | $28 | Hold |
1
| – | – | ﹤0.01% | 1131 |
|
|
2017
Q3 | $43 | Buy |
+1
| New | +$43 | ﹤0.01% | 1128 |
|